Relationship between dosage and response to lithium prophylaxis in recurrent depression
- 1 May 1976
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 133 (5) , 567-570
- https://doi.org/10.1176/ajp.133.5.567
Abstract
The authors analyzed the results of a multihospital collaborative study on the effectiveness of lithium prophylaxis in recurrent depression in terms of dosage and found that serum lithium levels between 0.5 and 0.7 mEq/liter and doses below 1000 mg/day were relatively ineffective in preventing recurrences. Serum lithium levels between 0.8 and 1.0 mEq/liter and doses above 1000 mg/day were associated with a relatively low failure rate. The authors discuss the relevance of these findings to current prescription guidelines for lithium carbonate.Keywords
This publication has 4 references indexed in Scilit:
- Lithium Carbonate and Imipramine in Prevention of Affective EpisodesArchives of General Psychiatry, 1973
- Lithium Carbonate Treatment of Psychiatric IllnessPublished by American Medical Association (AMA) ,1970
- Lithium Carbonate: A Clinical StudyAmerican Journal of Psychiatry, 1968
- Lithium in psychiatric therapy and prophylaxisJournal of Psychiatric Research, 1968